Jiangsu Apon Medical Technology Co., Ltd.

Equities

300753

CNE100003FV4

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
11.8 CNY +1.29% Intraday chart for Jiangsu Apon Medical Technology Co., Ltd. +11.85% -31.28%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Jiangsu Apon Medical Technology Co., Ltd. Proposes Final Dividend for 2023 CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
China and Hong Kong stocks close flat ahead of May manufacturing data RE
China, Hong Kong stocks fall ahead of May manufacturing data RE
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Jiangsu Apon Medical Technology Co., Ltd. Approves Management Appointments CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Apon Medical Technology Forgoes 2021 Dividend as Full-Year Profit Tanks 44% MT
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Certain A-Shares of Jiangsu Apon Medical Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 13-DEC-2021. CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Jiangsu Apon Medical Technology Co., Ltd. Implements A Shares Final Cash Distribution for 2020, Payable on June 2, 2021 CI
Jiangsu Apon Medical Technology Co., Ltd. Approves Final Dividend Profit Distribution Proposal for 2020 CI
Jiangsu Apon Medical Technology Co., Ltd. Announces Final Dividend Profit Distribution Proposal for 2020 CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020 CI
Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020 CI
Jiangsu Apon Medical Technology Co., Ltd. Announces Cash Dividend for 2019, Payable on 28 May 2020 CI
Jiangsu Apon Medical Technology Co., Ltd. Approves Proposed Final Cash Dividend for 2019 CI
Chart Jiangsu Apon Medical Technology Co., Ltd.
More charts
Jiangsu Apon Medical Technology Co., Ltd. is a China-based company which is mainly engaged in research, development, production and sales of medical device products for pain management and nasal care. The Company's main products include medical devices such as micro-computer injection pumps, disposable drug injection pumps, wireless analgesia management systems, pulse oximeters and sensors for pain management, and nasal care applications such as nasal care sprayers. Among them, medical devices used in the field of pain management are mainly used for infusion and monitoring of drug treatment in postoperative, childbirth, cancer and other clinical treatments to alleviate pain in patients; medical devices used in nasal care are mainly used to relieve nasal dryness, nasal congestion and nose discomfort such as bleeding in patients. The Company operates primarily in domestic and overseas markets.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 300753 Stock
  4. News Jiangsu Apon Medical Technology Co., Ltd.
  5. Apon Medical Technology Forgoes 2021 Dividend as Full-Year Profit Tanks 44%